论文信息 - Pharmacokinetic Studies in Hepatic Impairment: is the Maddrey function a Eelevant Marker? - 字舞流文

Pharmacokinetic Studies in Hepatic Impairment: is the Maddrey function a Eelevant Marker?

B. Ljungberg | M. Gårdmark | Monica Edholm

[1] S. G. Simonson,et al. PHARMACOKINETICS AND DISPOSITION Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment , 2003 .

[2] Steven R Deitcher,et al. Interpretation of the international normalised ratio in patients with liver disease , 2002, The Lancet.

[3] T. Salmonson,et al. Dosing recommendations in liver disease. , 1999, Clinical pharmacology and therapeutics.

[4] R. Carithers,et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. , 1989, Annals of internal medicine.

[5] Willis C. Maddrey,et al. Corticosteroid therapy of alcoholic hepatitis. , 1978, Gastroenterology.

[6] R. White,et al. Corticosteroid therapy of alcoholic hepatitis. , 1978, Gastroenterology.